Q2 profit rises 57% as fermentation capacity doubles to 990 KL

Pat Growth 25pctEbitda Margin ExpansionResults View source PDF Explain this filing

GUJTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.6%Reaction day

₹451.50

prior close

₹462.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-0.3% vs market

Pharmaceuticals peers, median of 157sector-0.2%-0.4% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.3

10m

-1.9

15m

-2.1

30m

-2.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.6-0.3-0.3-0.2-0.4

Next day

-0.3+0.7-1.0+0.5-0.8

+0.3+0.6-0.2+0.6-0.2

-1.4+0.5-1.8+0.5-1.8

-1.1+1.1-2.2+0.4-1.5

-4.1+0.3-4.4-0.6-3.5

-6.3-0.2-6.1-1.1-5.3

15d

-11.4-2.2-9.2-2.0-9.5

-13.2-4.9-8.2-2.9-10.3

-16.3-7.5-8.8-5.8-10.4

-26.9-4.8-22.2-6.4-20.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q2 revenue rose 18% from the previous quarter to Rs 42.35 crore. Profit after tax increased 57% to Rs 14.26 crore, with EPS of Rs 1.31. Half-year revenue was Rs 79.31 crore and profit after tax was Rs 23.35 crore, up 119% year on year. Operating cash flow was Rs 37.92 crore, while borrowings rose to Rs 68.96 crore.

Likely market impact

Strong profit growth and cash generation may support the stock, but higher borrowings and capacity execution could limit gains.